Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 059227/0425 | |
| Pages: | 6 |
| | Recorded: | 03/10/2022 | | |
| Attorney Dkt #: | 050723-568N01US + RELATED |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
8
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/30/2022
|
Application #:
|
16469091
|
Filing Dt:
|
06/12/2019
|
|
Publication #:
|
|
Pub Dt:
|
02/27/2020
| | | | |
|
Title:
|
ANTI-CD19 HUMANIZED ANTIBODY AND IMMUNE EFFECTOR CELL TARGETING CD19
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/13/2022
|
Application #:
|
16479365
|
Filing Dt:
|
07/19/2019
|
|
Publication #:
|
|
Pub Dt:
|
11/28/2019
| | | | |
|
Title:
|
BCMA-TARGETING ANTIBODY AND USE THEREOF
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16645247
|
Filing Dt:
|
03/06/2020
|
|
Publication #:
|
|
Pub Dt:
|
08/20/2020
| | | | |
|
Title:
|
GENETICALLY ENGINEERED T CELL AND APPLICATION THEREOF
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16963095
|
Filing Dt:
|
07/17/2020
|
|
Publication #:
|
|
Pub Dt:
|
11/05/2020
| | | | |
|
Title:
|
SYNNOTCH RECEPTOR-REGULATED EXPRESSION OF IL12
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16979102
|
Filing Dt:
|
09/08/2020
|
|
Publication #:
|
|
Pub Dt:
|
04/14/2022
| | | | |
|
Title:
|
METHOD AND COMPOSITION FOR TREATING TUMORS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17052425
|
Filing Dt:
|
11/02/2020
|
|
Publication #:
|
|
Pub Dt:
|
04/28/2022
| | | | |
|
Title:
|
IMMUNE EFFECTOR CELL AND USE THEREOF
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17055470
|
Filing Dt:
|
11/13/2020
|
|
Publication #:
|
|
Pub Dt:
|
07/15/2021
| | | | |
|
Title:
|
GENETICALLY ENGINEERED CELL AND APPLICATION THEREOF
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17281372
|
Filing Dt:
|
03/30/2021
|
|
Publication #:
|
|
Pub Dt:
|
02/03/2022
| | | | |
|
Title:
|
COMBINATION THERAPY OF CLDN18 ANTIBODY AND CHEMOTHERAPY DRUGS
|
|
|
Assignee
|
|
|
|
|
| RM12, 20/F, HO KING COMM CTR, 2-16 FAYUEN ST |
| MONGKOK KOWLOON |
| HONG KONG, CHINA |
|
|
Correspondence name and address
|
| |
WILLIAM B. KEZER
|
| |
MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, PC
|
| |
44 MONTGOMERY STREET, 36TH FLOOR
|
| |
SAN FRANCISCO, CA 94104
|
Search Results as of:
05/28/2024 10:38 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
